secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2023-04-27T23:59:59+00:00
Accession:  0001213900-23-033248
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq grants Bluejay Diagnostics extension to Oct 23, 2023 to regain $1 bid price
--------------------------------------------------------------------------------

- Company received original deficiency notice on Oct 25, 2022 for bid price below $1.
- Nasdaq extended compliance deadline to Oct 23, 2023; must close at $1+ for 10 consecutive days.
- Company may implement a reverse stock split, subject to stockholder approval, to regain compliance.
- If not compliant by deadline, Nasdaq will delist the stock; appeal rights available.
- No assurance of regaining or maintaining compliance with Nasdaq listing requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390023033248/0001213900-23-033248-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390023033248/ea177565-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-033248

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer